Humacyte Inc (HUMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 1,301 | 233 | 177 | 241 | 690 |
| Gross Profit | 1,301 | 233 | 177 | 241 | 690 |
| Operating Expenses | 19,832 | 21,996 | 21,804 | 20,784 | 19,959 |
| Operating Income | -18,531 | -21,763 | -21,627 | -20,543 | -19,269 |
| Interest Expense | 1,488 | 1,432 | 1,396 | 1,204 | 1,215 |
| Other Income | 56,887 | 3,363 | 65,608 | -9,816 | 3,286 |
| Pre-tax Income | 36,868 | -19,832 | 42,585 | -31,563 | -17,198 |
| Net Income Continuous | 36,868 | -19,832 | 42,585 | -31,563 | -17,198 |
| Net Income | $36,868 | $-19,832 | $42,585 | $-31,563 | $-17,198 |
| EPS Basic Total Ops | 0.36 | -0.19 | 6.41 | -0.72 | -2.89 |
| EPS Basic Continuous Ops | 0.36 | -0.19 | 6.41 | -0.72 | -2.89 |
| EPS Diluted Total Ops | 0.35 | -0.19 | 6.41 | -0.72 | -2.89 |
| EPS Diluted Continuous Ops | 0.35 | -0.19 | 6.41 | -0.72 | -2.89 |
| EBITDA(a) | $-16,117 | $-19,345 | $-19,232 | $-18,169 | $-16,890 |